{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:46:41Z","timestamp":1782312401299,"version":"3.54.5"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG073410\u201001"],"award-info":[{"award-number":["R01AG073410\u201001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24DA061696\u201001"],"award-info":[{"award-number":["K24DA061696\u201001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Services Research"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe patterns of gabapentinoid (Gabapentin and Pregabalin) use and concurrent use with other central nervous system (CNS) acting pain medications (opioids and benzodiazepines) among US Medicare beneficiaries following acute ischemic stroke (AIS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Setting and Design<\/jats:title>\n                    <jats:p>We analyzed new outpatient gabapentinoid prescriptions in older stroke survivors between 2009 and 2022. We calculated the percent of new gabapentinoid initiators within 6\u2009months of stroke discharge and analyzed concurrent pain medications prescribed within 30\u2009days of gabapentinoid initiation. We presented trends and geographic patterns standardized by age, discharge destination, and modified Rankin Scale (mRS) to control for variations in the sample composition by age and stroke severity over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources and Analytic Sample<\/jats:title>\n                    <jats:p>We analyzed a 20% sample of US Medicare beneficiaries aged 65\u2009years or older who were hospitalized for AIS. We included those who met Medicare enrollment criteria, had no prior stroke, no prior gabapentinoid use within 6\u2009months, and were discharged home within 30\u2009days of hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Principal Findings<\/jats:title>\n                    <jats:p>Among 153,728 stroke survivors, 4.9% received new gabapentinoid prescriptions within 6\u2009months postdischarge. Of the 7595 gabapentinoid initiators, 1579 (21%) had concurrent opioid and 653 (8.6%) had concurrent benzodiazepine prescriptions. In the sample, the median age was 78\u2009years (Quartile Range: 72\u201384), 55% were female, and 81% were non\u2010Hispanic White. The standardized percentage of gabapentinoid initiators increased from 3.8% in 2009 to 5.9% in 2022 (crude: 3.6% in 2009 to 5.8% in 2022). Despite increases in the number of gabapentinoid initiators, the percentage of concurrent opioid users remained low over time, around 1% of the study population. We observed variation in gabapentinoid initiation and concurrent use with opioids by geography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>From 2009 to 2022, poststroke gabapentinoid use increased in older adults, but concurrent use with opioids remained low over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1475-6773.70133","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:24:44Z","timestamp":1779269084000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gabapentinoid Polypharmacy Among Medicare Beneficiaries During the Poststroke Recovery Period"],"prefix":"10.1111","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7624-2423","authenticated-orcid":false,"given":"Julianne D.","family":"Brooks","sequence":"first","affiliation":[{"name":"Department of Neurology Massachusetts General Hospital  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8689-5148","authenticated-orcid":false,"given":"Rebeka Bustamante","family":"Rocha","sequence":"additional","affiliation":[{"name":"Department of Neurology Massachusetts General Hospital  Boston Massachusetts USA"},{"name":"Department of Neurology Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-7794","authenticated-orcid":false,"given":"Maria A.","family":"Donahue","sequence":"additional","affiliation":[{"name":"Department of Neurology Massachusetts General Hospital  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-3203","authenticated-orcid":false,"given":"Joseph P.","family":"Newhouse","sequence":"additional","affiliation":[{"name":"Department of Health Care Policy Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Health Policy and Management Harvard T.H. Chan School of Public Health  Boston Massachusetts USA"},{"name":"Harvard Kennedy School  Cambridge Massachusetts USA"},{"name":"National Bureau of Economic Research  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Haneuse","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Harvard T.H. Chan School of Public Health  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-7917","authenticated-orcid":false,"given":"Alexander C.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Epidemiology Harvard T.H. Chan School of Public Health  Boston Massachusetts USA"},{"name":"Center for Global Health and Mongan Institute Massachusetts General Hospital  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1191-1315","authenticated-orcid":false,"given":"Lidia M. V. R.","family":"Moura","sequence":"additional","affiliation":[{"name":"Department of Neurology Massachusetts General Hospital  Boston Massachusetts USA"},{"name":"Department of Neurology Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Epidemiology Harvard T.H. Chan School of Public Health  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.3052"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.7856"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7119a3"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.08.024"},{"key":"e_1_2_10_6_1","unstructured":"U.S. Food and Drug Administration (FDA) \u201cFDA Warns About Serious Breathing Problems With Seizure and Nerve Pain Medicines Gabapentin (Neurontin Gralise Horizant) and Pregabalin (Lyrica Lyrica CR) \u201daccessed January 27 2026 https:\/\/www.fda.gov\/drugs\/drug\u2010safety\u2010and\u2010availability\/fda\u2010warns\u2010about\u2010serious\u2010breathing\u2010problems\u2010seizure\u2010and\u2010nerve\u2010pain\u2010medicines\u2010gabapentin\u2010neurontin."},{"key":"e_1_2_10_7_1","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society Beers Criteria Update Expert Panel \u201cAmerican Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults \u201d71 no.7(2023) 2052\u20132081 https:\/\/doi.org\/10.1111\/jgs.18372.","DOI":"10.1111\/jgs.18372"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.0086"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.043355"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.489294"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnv019"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.18626"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266\u2010024\u201001130\u2010z"},{"key":"e_1_2_10_14_1","unstructured":"\u201cGuidelines for Adult Stroke Rehabilitation and Recovery \u201d10.1161\/STR.0000000000000098."},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010147\u20108\u2010200710160\u201000010"},{"key":"e_1_2_10_16_1","unstructured":"Centers for Medicare and Medicaid Services \u201cCenters for Medicare and Medicaid Services \u201daccessed January 7 2025 https:\/\/www.cms.gov."},{"key":"e_1_2_10_17_1","unstructured":"ResDAC (Research Data Assistance Center) \u201cMedicare Provider Analysis and Review (MedPAR) \u201daccessed January 7 2025 https:\/\/resdac.org\/cms\u2010data\/files\/medpar."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135834"},{"issue":"3","key":"e_1_2_10_19_1","first-page":"27","article-title":"More Accurate Racial and Ethnic Codes for Medicare Administrative Data","volume":"29","author":"Eicheldinger C.","year":"2008","journal-title":"Health Care Financing Review"},{"key":"e_1_2_10_20_1","unstructured":"Chronic Conditions Data Warehouse \u201cChronic Conditions Data Warehouse \u201d2025 accessed January 7 2025 https:\/\/www2.ccwdata.org\/web\/guest\/home\/."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/003693305700200504"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.11.2027"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034480"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.041635"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3019"},{"key":"e_1_2_10_26_1","unstructured":"\u201cStatistical Power Analysis for the Behavioral Sciences\u2014National Institutes of Health \u201daccessed July 29 2025 https:\/\/onesearch.nihlibrary.ors.nih.gov\/discovery\/fulldisplay\/cdi_askewsholts_vlebooks_9781134742776\/01NIH_INST:NIH."},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.607630"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/rapm\u20102025\u2010106577"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.910719"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15532"},{"key":"e_1_2_10_31_1","unstructured":"\u201cGabapentin Opioids and the Risk of Opioid\u2010Related Death: A Population\u2010Based Nested Case\u2010Control Study \u201daccessed July 29 2025 https:\/\/pubmed\u2010ncbi\u2010nlm\u2010nih\u2010gov.treadwell.idm.oclc.org\/28972983\/."},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010018\u20100695\u20106"},{"key":"e_1_2_10_33_1","unstructured":"\u201cFull Prescribing Information: Pregabalin \u201dFood and Drug Administration (FDA) 2012 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021446s028lbl.pdf."},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.12.023"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000211"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(09)70176\u20100"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.3.246"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2024.08.033"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S345521"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.12.001"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003921"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104605"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S168504"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010021\u201007314\u20102"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.NT.0000830928.96207.f3"}],"container-title":["Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1475-6773.70133","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1475-6773.70133","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1475-6773.70133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:56:00Z","timestamp":1782309360000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1475-6773.70133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1111\/1475-6773.70133"],"URL":"https:\/\/doi.org\/10.1111\/1475-6773.70133","archive":["Portico"],"relation":{},"ISSN":["0017-9124","1475-6773"],"issn-type":[{"value":"0017-9124","type":"print"},{"value":"1475-6773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"2025-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70133"}}